Active
Small Business
Overview
- Legal name
- MELINTA THERAPEUTICS, LLC
- Registered location
- PARSIPPANY, NJ, USA
- Website
- Company website ↗
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- Latest award activity
- Jul 9, 2026
Read company summary
MELINTA THERAPEUTICS, LLC is associated with UEI H8K6F2A4KD49 and CAGE 7XFT1 in public federal records. AcornBids currently links 3 prime awards totaling $47.5M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology); Pharmaceutical Preparation Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325412 (Pharmaceutical Preparation Manufacturing). Its public SAM.gov registration lists PARSIPPANY, NJ, USA.
At a glance
Lifetime prime obligations$47.5M
Prime awards3
Awards with future end dates1
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 27, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- MELINTA THERAPEUTICS, LLC
- UEI
- H8K6F2A4KD49
- CAGE
- 7XFT1
- Registered address
- 389 INTERPACE PKWY STE 450, PARSIPPANY, NJ, 07054, USA
- Registration status
- Active
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- SAM activation
- Oct 24, 2025
- Initial registration
- Mar 29, 2018
- Entity start
- Nov 18, 2005
- SAM updated
- Oct 27, 2025
- Registration expires
- Oct 22, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 36F79724D017865 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | $25.5M | Sep 1, 2024 | Not available |
| 75A50123C00022ADVANCE THE DEVELOPMENT OF TWO ANTIBIOTICS FOR USE IN THE PEDIATRIC POPULATION FOR THE TREATMENT OF SERIOUS BACTERIAL INFECTIONS WHERE MULTIDRUG-RESISTANT ORGANISMS ARE COMMON… | Department of Health and Human Services | $47.5M | Jul 6, 2023 | Aug 6, 2034 |
| 36E79724A0033BPA FOR REZZAYO | Department of Veterans Affairs | $7.3K | Sep 20, 2024 | Not available |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Oct 27, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Mar 29, 2018 |
| Entity start | Nov 18, 2005 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| 551114 — Corporate, Subsidiary, and Regional Managing Offices | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| IRIS TRAN | Government business | Contact method not published | SAM registration | Not available |
| LAUREN DOLAK | Alternate government business | Contact method not published | SAM registration | Not available |
| LAUREN DOLAK | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325412 — Pharmaceutical Preparation Manufacturing
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- 551114 — Corporate, Subsidiary, and Regional Managing Offices
Registered products and services
- 6505 — Drugs and Biologicals
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
29 awards
25 awards
23 awards
19 awards
18 awards
15 awards
14 awards
About MELINTA THERAPEUTICS, LLC
What products and services appear in its federal awards?
Recorded award industries: 541714 — Research and Development in Biotechnology (except Nanobiotechnology); 325412 — Pharmaceutical Preparation Manufacturing.
Recorded products and services: AN44 — HEALTH R&D SERVICES; HEALTH CARE - OTHER; R&D ADMINISTRATIVE EXPENSES; 6505 — Drugs and Biologicals.
Examples from recent award records:
- 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
- ADVANCE THE DEVELOPMENT OF TWO ANTIBIOTICS FOR USE IN THE PEDIATRIC POPULATION FOR THE TREATMENT OF SERIOUS BACTERIAL INFECTIONS WHERE MULTIDRUG-RESISTANT ORGANISMS ARE COMMON…
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
389 INTERPACE PKWY STE 450, PARSIPPANY, New Jersey 07054, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
325412 — Pharmaceutical Preparation Manufacturing.
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services; Department of Veterans Affairs.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit